Future studies will be required to determine if the synthetic lethal effect of C/EBPβ deletion in vivo in skin tumors is applicable to other mouse model systems/tumor types and forms of oncogenic Ras (Ha, Ki, N). This evidence concerns the gene CEBPB and skin neoplasm.